Study of E7046 in Subjects With Selected Advanced Malignancies
Status:
Terminated
Trial end date:
2018-02-27
Target enrollment:
Participant gender:
Summary
This is an open label, multicenter, Phase 1 study of E7046 to assess the safety and
tolerability of E7046 and to determine the maximum tolerated dose (MTD) and/or the
recommended Phase 2 dose (RP2D) of E7046.